Godman B;Bucsics A;Burkhardt T;Piessnegger J;Schmitzer M;Barbui C;Raschi E;Bennie M;Gustafsson LL, Potential to enhance the prescribing of generic drugs in patients with mental health problems in austria; implications for the future, «FRONTIERS IN PHARMACOLOGY», 2013, 3, Article number: 198 , pp. 1 - 10 [Scientific article]
Raschi E.; Piccinni C.; Poluzzi E.; Marchesini G.; De Ponti F., The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database., «ACTA DIABETOLOGICA», 2013, 50, pp. 569 - 577 [Scientific article]
Raschi E;Poluzzi E;Godman B;Koci A;Moretti U;Kalaba M;Bennie M;Barbui C;Wettermark B;Sturkenboom M;De Ponti F, Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe., «PLOS ONE», 2013, 8, pp. 1 - 14 [Scientific article]Open Access
Piccinni C; Raschi E; Poluzzi E; Puccini A; Cars T; Wettermark B; Diemberger I; Boriani G; De Ponti F., Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden., «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2013, 69, pp. 715 - 720 [Scientific article]
C. Piccinni; E. Poluzzi; E. Raschi; B. Vitamia; A. Koci; F. De Ponti, Use and Perception of Phytoestrogens
in Postmenopausal Women: Result
of a Questionnaire-Based Survey, in: ABSTRACTS, Adis, «DRUG SAFETY», 2013, pp. 867 - 868 (atti di: 13th ISoP Annual Meeting: ‘‘The Renaissance of Pharmacovigilance’’, Pisa, 01-04/10/2014) [Poster]
Motola D.; Piccinni C.; Biagi C.; Raschi E.; Marra A.; Marchesini G.; Poluzzi E., Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database., «DRUG SAFETY», 2012, 35, pp. 315 - 323 [Scientific article]
Raschi E.; De Ponti F., Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology., «INTERNAL AND EMERGENCY MEDICINE», 2012, 7, pp. 113 - 131 [Scientific article]
Elisabetta Poluzzi; Emanuel Raschi; Carlo Piccinni; Fabrizio De Ponti, Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS), in: Data Mining Applications in Engineering and Medicine, RIJEKA, InTech, 2012, pp. 265 - 302 [Chapter or essay]
Piccinni C; Raschi E; Poluzzi E; Puccini A; Cars T; Wettermark B; Diemberger I; Boriani G; De Ponti F, Impact of dronedarone authorisation on antiarrhythmic utilisation: interrupted time series strategy on Italian and Swedish prescription databases, in: Abstracts, 2012, pp. 1 - 1 (atti di: XVI Seminario Nazionale Dottorandi e Assegnisti in Farmacologia ed affini, Rimini, 16-19 settembre 2012) [Abstract]
Piccinni C; Raschi E; Poluzzi E; Puccini A; Cars T; Wettermark B; Diemberger I; Boriani G; De Ponti F., Interrupted time series analysis on the impact of dronedarone authorisation on Italian and Swedish antiarrhythmic prescriptions, in: ABSTRACTS, Wiley Blackewell, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2012, 21, pp. 290 - 291 (atti di: 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Barcelona, August 23-26, 2012) [Abstract]
E. Raschi; E. Poluzzi, Apparato Gastroenterico, in: WALLER D.G. RENWICK A.G. HILLIER K., Farmacologia Medica ed Elementi di Terapia, III Edizione, MILANO, Elsevier, 2011, pp. 339 - 379 . Opera originale: Autore: Waller, Renwick, Hillier - Titolo: Medical Pharmacology and Therapeutics [Book contributions (translation)]
E. Raschi; F. De Ponti, Gestione del Rischio e Farmacologia, in: MAURO MARTINI CRISTIANO PELATI, La Gestione del Rischio Clinico, MILANO, McGraw-Hill, 2011, pp. 241 - 261 [Chapter or essay]
Raschi E.; Piccinni C.; Poluzzi E.; De Ponti F., Impact of notoriety bias on reporting of pancreatitis with antidiabetics: the case of exenatide, in: ABSTRACTS ONLINE, Bologna, Società Italiana di Farmacologia, 2011, pp. 186 - 186 (atti di: 35° Congresso Nazionale della Società Italiana di Farmacologia, Bologna, Italia, 14-17 Settembre 2011) [Abstract]
Raschi E; Poluzzi E; Koci A; Boriani G; De Ponti F., QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2011, 72, pp. 839 - 841 [Comment or similar]
E. Raschi; E. Poluzzi; A. Koci; G. Boriani; F. De Ponti, QT shortening among suspected adverse drug reactions reported to the FDA: a case-by-case analysis, in: Special Issue: Abstracts of the 10th Congress of the European Association for Clinical Pharmacology and Therapeutics, 26-29 June 2011, Budapest, Hungary, «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2011, 109, pp. 56 - 164 (atti di: 10th Congress of the European Association for Clinical Pharmacology and Therapeutics, Budapest, June 26-29) [Abstract]
